Designing Lead Optimisation of MMP-12 Inhibitors

The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles,...

Full description

Bibliographic Details
Main Authors: Matteo Borrotti, Davide De March, Debora Slanzi, Irene Poli
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Computational and Mathematical Methods in Medicine
Online Access:http://dx.doi.org/10.1155/2014/258627
id doaj-2594c927d2114712a7bc5048d9bc2e12
record_format Article
spelling doaj-2594c927d2114712a7bc5048d9bc2e122020-11-24T23:46:43ZengHindawi LimitedComputational and Mathematical Methods in Medicine1748-670X1748-67182014-01-01201410.1155/2014/258627258627Designing Lead Optimisation of MMP-12 InhibitorsMatteo Borrotti0Davide De March1Debora Slanzi2Irene Poli3European Centre for Living Technology, 30124 Venice, ItalyEuropean Centre for Living Technology, 30124 Venice, ItalyEuropean Centre for Living Technology, 30124 Venice, ItalyEuropean Centre for Living Technology, 30124 Venice, ItalyThe design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles, which is a very long and laborious process. In this paper we address the so-called lead optimisation process by developing a new strategy to design experiments and modelling data, namely, the evolutionary model-based design for optimisation (EDO). This approach is developed on a very small set of experimental points, which change in relation to the response of the experimentation according to the principle of evolution and insights gained through statistical models. This new procedure is validated on a data set provided as test environment by Pickett et al. (2011), and the results are analysed and compared to the genetic algorithm optimisation (GAO) as a benchmark. The very good performance of the EDO approach is shown in its capacity to uncover the optimum value using a very limited set of experimental points, avoiding unnecessary experimentation.http://dx.doi.org/10.1155/2014/258627
collection DOAJ
language English
format Article
sources DOAJ
author Matteo Borrotti
Davide De March
Debora Slanzi
Irene Poli
spellingShingle Matteo Borrotti
Davide De March
Debora Slanzi
Irene Poli
Designing Lead Optimisation of MMP-12 Inhibitors
Computational and Mathematical Methods in Medicine
author_facet Matteo Borrotti
Davide De March
Debora Slanzi
Irene Poli
author_sort Matteo Borrotti
title Designing Lead Optimisation of MMP-12 Inhibitors
title_short Designing Lead Optimisation of MMP-12 Inhibitors
title_full Designing Lead Optimisation of MMP-12 Inhibitors
title_fullStr Designing Lead Optimisation of MMP-12 Inhibitors
title_full_unstemmed Designing Lead Optimisation of MMP-12 Inhibitors
title_sort designing lead optimisation of mmp-12 inhibitors
publisher Hindawi Limited
series Computational and Mathematical Methods in Medicine
issn 1748-670X
1748-6718
publishDate 2014-01-01
description The design of new molecules with desired properties is in general a very difficult problem, involving heavy experimentation with high investment of resources and possible negative impact on the environment. The standard approach consists of iteration among formulation, synthesis, and testing cycles, which is a very long and laborious process. In this paper we address the so-called lead optimisation process by developing a new strategy to design experiments and modelling data, namely, the evolutionary model-based design for optimisation (EDO). This approach is developed on a very small set of experimental points, which change in relation to the response of the experimentation according to the principle of evolution and insights gained through statistical models. This new procedure is validated on a data set provided as test environment by Pickett et al. (2011), and the results are analysed and compared to the genetic algorithm optimisation (GAO) as a benchmark. The very good performance of the EDO approach is shown in its capacity to uncover the optimum value using a very limited set of experimental points, avoiding unnecessary experimentation.
url http://dx.doi.org/10.1155/2014/258627
work_keys_str_mv AT matteoborrotti designingleadoptimisationofmmp12inhibitors
AT davidedemarch designingleadoptimisationofmmp12inhibitors
AT deboraslanzi designingleadoptimisationofmmp12inhibitors
AT irenepoli designingleadoptimisationofmmp12inhibitors
_version_ 1725492548040916992